Approval · Notice of Compliance 8156 · 2006
MICRO + 6 REGULAR: Notice of Compliance 8156
Issued July 18, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8156
- Date
- July 18, 2006
- Company
- Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Multi-trace element
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MICRO + 6 REGULAR | 02091119 | Cancelled Post Market |
| MICRO + 6 CONCENTRATE | 02091127 | Cancelled Post Market |
| MICRO + 6 PEDIATRIC | 02091100 | Cancelled Post Market |